Cargando…
Identification of cancer driver genes based on nucleotide context
Cancer genomes contain large numbers of somatic mutations, but few of these mutations drive tumor development. Current approaches identify driver genes based on mutational recurrence, or they approximate the functional consequences of nonsynonymous mutations using bioinformatic scores. While passeng...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031046/ https://www.ncbi.nlm.nih.gov/pubmed/32015527 http://dx.doi.org/10.1038/s41588-019-0572-y |
_version_ | 1783499291013152768 |
---|---|
author | Dietlein, Felix Weghorn, Donate Taylor-Weiner, Amaro Richters, André Reardon, Brendan Liu, David Lander, Eric S. Van Allen, Eliezer M. Sunyaev, Shamil R. |
author_facet | Dietlein, Felix Weghorn, Donate Taylor-Weiner, Amaro Richters, André Reardon, Brendan Liu, David Lander, Eric S. Van Allen, Eliezer M. Sunyaev, Shamil R. |
author_sort | Dietlein, Felix |
collection | PubMed |
description | Cancer genomes contain large numbers of somatic mutations, but few of these mutations drive tumor development. Current approaches identify driver genes based on mutational recurrence, or they approximate the functional consequences of nonsynonymous mutations using bioinformatic scores. While passenger mutations are enriched in characteristic nucleotide contexts, driver mutations occur in functional positions, which are not necessarily surrounded by a particular nucleotide context. We observed that mutations in contexts that deviate from the characteristic contexts around passenger mutations provide a signal in favor of driver genes. We therefore developed a method that combines this feature with the signals traditionally used for driver gene identification. We applied our method to whole-exome sequencing data from 11,873 tumor-normal pairs and identified 460 driver genes that clustered into 21 cancer-related pathways. Our study provides a resource of driver genes across 28 tumor types with additional driver genes identified based on mutations in unusual nucleotide contexts. |
format | Online Article Text |
id | pubmed-7031046 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-70310462020-08-03 Identification of cancer driver genes based on nucleotide context Dietlein, Felix Weghorn, Donate Taylor-Weiner, Amaro Richters, André Reardon, Brendan Liu, David Lander, Eric S. Van Allen, Eliezer M. Sunyaev, Shamil R. Nat Genet Article Cancer genomes contain large numbers of somatic mutations, but few of these mutations drive tumor development. Current approaches identify driver genes based on mutational recurrence, or they approximate the functional consequences of nonsynonymous mutations using bioinformatic scores. While passenger mutations are enriched in characteristic nucleotide contexts, driver mutations occur in functional positions, which are not necessarily surrounded by a particular nucleotide context. We observed that mutations in contexts that deviate from the characteristic contexts around passenger mutations provide a signal in favor of driver genes. We therefore developed a method that combines this feature with the signals traditionally used for driver gene identification. We applied our method to whole-exome sequencing data from 11,873 tumor-normal pairs and identified 460 driver genes that clustered into 21 cancer-related pathways. Our study provides a resource of driver genes across 28 tumor types with additional driver genes identified based on mutations in unusual nucleotide contexts. 2020-02-03 2020-02 /pmc/articles/PMC7031046/ /pubmed/32015527 http://dx.doi.org/10.1038/s41588-019-0572-y Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Dietlein, Felix Weghorn, Donate Taylor-Weiner, Amaro Richters, André Reardon, Brendan Liu, David Lander, Eric S. Van Allen, Eliezer M. Sunyaev, Shamil R. Identification of cancer driver genes based on nucleotide context |
title | Identification of cancer driver genes based on nucleotide context |
title_full | Identification of cancer driver genes based on nucleotide context |
title_fullStr | Identification of cancer driver genes based on nucleotide context |
title_full_unstemmed | Identification of cancer driver genes based on nucleotide context |
title_short | Identification of cancer driver genes based on nucleotide context |
title_sort | identification of cancer driver genes based on nucleotide context |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031046/ https://www.ncbi.nlm.nih.gov/pubmed/32015527 http://dx.doi.org/10.1038/s41588-019-0572-y |
work_keys_str_mv | AT dietleinfelix identificationofcancerdrivergenesbasedonnucleotidecontext AT weghorndonate identificationofcancerdrivergenesbasedonnucleotidecontext AT taylorweineramaro identificationofcancerdrivergenesbasedonnucleotidecontext AT richtersandre identificationofcancerdrivergenesbasedonnucleotidecontext AT reardonbrendan identificationofcancerdrivergenesbasedonnucleotidecontext AT liudavid identificationofcancerdrivergenesbasedonnucleotidecontext AT landererics identificationofcancerdrivergenesbasedonnucleotidecontext AT vanalleneliezerm identificationofcancerdrivergenesbasedonnucleotidecontext AT sunyaevshamilr identificationofcancerdrivergenesbasedonnucleotidecontext |